TGFB1 and chronic obstructive pulmonary disease: Fluocinolone acetonide is a stronger potentiator than other corticosteroids of the TGF-β pathway [48], which is noted to be dysregulated in COPD [49], and fluocinolone acetonide may be more effective than comparable corticosteroids in improved homeostasis in that pathway.